Valuation: Xcelerate Inc.

Market Cap 9.49M 8.48M 7.83M 7.1M 13.28M 901M 13.5M 94.24M 37.31M 472M 35.62M 34.87M 1.49B P/E 2022
-16x
P/E 2023 -5.46x
Enterprise Value 10.7M 9.55M 8.82M 8M 14.96M 1.02B 15.21M 106M 42.04M 532M 40.15M 39.29M 1.68B EV / Sales 2022
-
EV / Sales 2023 15,004,302x
Free-Float
58.58%
Yield 2022 *
-
Yield 2023 -
1 day+2.08%
1 week+0.14%
Current month+21.90%
1 month+16.36%
3 months+133.05%
6 months+100.00%
Current year+192.57%
1 week 0.02
Extreme 0.0237
0.03
1 month 0.02
Extreme 0.0202
0.03
Current year 0.01
Extreme 0.0067
0.03
1 year 0.01
Extreme 0.0061
0.03
3 years 0.01
Extreme 0.0061
0.06
5 years 0.01
Extreme 0.0061
0.14
10 years 0
Extreme 0.0004
0.17
Manager TitleAgeSince
Chief Executive Officer - 01/05/2020
Chief Tech/Sci/R&D Officer - 04/09/2020
Director TitleAgeSince
Director/Board Member - 23/07/2020
Chairman - -
Director/Board Member - 04/08/2020
Change 5-day change 1-year change 3-year change Capi.($)
+2.08%+0.14%+114.23%-54.80% 11.11M
-1.07%+1.20%+14.09%+35.52% 120B
+0.37%+2.22%+4.92%+103.82% 102B
+0.64%+2.67%+109.83%+890.32% 58.23B
+1.75%+2.27%-5.92%+83.08% 29.08B
-0.57%+2.93%+32.78%+95.74% 26.61B
-0.30%+3.46%+17.70%+65.59% 26.68B
-0.81%+0.45%+27.60%+378.95% 21.62B
+1.48%-4.05%-22.32%-8.19% 19.58B
-0.68%+2.72%+3.48%+85.69% 18.93B
Average +0.29%+0.17%+29.64%+167.57% 42.18B
Weighted average by Cap. -0.06%+1.64%+23.65%+196.76%

Financials

2022 2023
Net sales - 1.12 1 0.93 0.84 1.57 106.52 1.6 11.14 4.41 55.81 4.21 4.12 175.95
Net income -845K -754K -697K -631K -1.18M -80.18M -1.2M -8.38M -3.32M -42.01M -3.17M -3.1M -132M -2.75M -2.46M -2.27M -2.06M -3.85M -261M -3.91M -27.31M -10.81M -137M -10.32M -10.1M -431M
Net Debt 113K 101K 93.43K 84.67K 158K 10.75M 161K 1.12M 445K 5.63M 425K 416K 17.76M 1.2M 1.08M 994K 901K 1.69M 114M 1.71M 11.96M 4.73M 59.92M 4.52M 4.43M 189M
Projected Income Statement - Annual - Xcelerate Inc.
Logo Xcelerate Inc.
Xcelerate, Inc. is a healthcare services and products company. The Company is engaged in three separate but related businesses within the medical, health and wellness sectors. The Company is focused on the development of medical technology and virtual health services to help patients in developing countries meet their medical needs by extending the reach of physicians through the technology; the formulation, packaging and marketing of consumer health and beauty, clinically tested skin and hair care products, and owning and licensing the rights to various forms of medical equipment.
Employees
12
Date Price Change Volume
23/10/26 $0.0256 +2.08% 8,500
21/10/26 $0.0251 +0.20% 143,000
20/10/26 $0.0250 +0.06% 31,815
19/10/26 $0.0250 -2.27% 47,001
16/10/26 $0.0256 -0.14% 45,000
  1. Stock Market
  2. Stocks
  3. XCRT Stock